(Q45352623)

English

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation

scientific article published on 22 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation (English)

1 reference

Europe PubMed Central

13 December 2017

1 reference

based on heuristic

inferred from title

liver transplantation

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Deepak Joshi

1

1 reference

Europe PubMed Central

13 December 2017

Siamak Salehi

2

1 reference

Europe PubMed Central

13 December 2017

Helen Brereton

3

1 reference

Europe PubMed Central

13 December 2017

Matthew Arno

4

1 reference

Europe PubMed Central

13 December 2017

Alberto Quaglia

5

1 reference

Europe PubMed Central

13 December 2017

Nigel Heaton

6

1 reference

Europe PubMed Central

13 December 2017

John O'Grady

7

1 reference

Europe PubMed Central

13 December 2017

Kosh Agarwal

8

1 reference

Europe PubMed Central

13 December 2017

Varuna Aluvihare

9

1 reference

Europe PubMed Central

13 December 2017

publication date

22 March 2013

1 reference

Europe PubMed Central

13 December 2017

Liver Transplantation

1 reference

Europe PubMed Central

13 December 2017

19

1 reference

Europe PubMed Central

13 December 2017

4

1 reference

Europe PubMed Central

13 December 2017

383-394

1 reference

Europe PubMed Central

13 December 2017

Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

The natural history of recurrent hepatitis C and what influences this

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Implications of micro-RNA profiling for cancer diagnosis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

The myb gene family in cell growth, differentiation and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

c-Myb is required for progenitor cell homeostasis in colonic crypts.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Secretory mechanisms and intercellular transfer of microRNAs in living cells

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

A practical guide to the management of HCV infection following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

A quantitative PCR method to detect blood microRNAs associated with tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

1 reference

https://api.crossref.org/works/10.1002%2FLT.23613

21 January 2018

Identifiers

10.1002/LT.23613

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45352623&oldid=2075532930"